A, G., A, M., L, B., A, F., O, D., D, A., . . . G, R. (2026). Clinical Value of Serum Cardiac Troponin I, Trimethylamine N-Oxide (TMAO), and Galectin-3 in Canine Myxomatous Mitral Valve Degeneration: A Preliminary Study. Veterinary sciences, 13(4), . https://doi.org/10.3390/vetsci13040335
Chicago Style (17th ed.) CitationA, Gavazza, Maggiori A, Biagini L, Fruganti A, Domenech O, Arletti D, Muollo MC, Masci C, and Rossi G. "Clinical Value of Serum Cardiac Troponin I, Trimethylamine N-Oxide (TMAO), and Galectin-3 in Canine Myxomatous Mitral Valve Degeneration: A Preliminary Study." Veterinary Sciences 13, no. 4 (2026). https://doi.org/10.3390/vetsci13040335.
MLA (9th ed.) CitationA, Gavazza, et al. "Clinical Value of Serum Cardiac Troponin I, Trimethylamine N-Oxide (TMAO), and Galectin-3 in Canine Myxomatous Mitral Valve Degeneration: A Preliminary Study." Veterinary Sciences, vol. 13, no. 4, 2026, https://doi.org/10.3390/vetsci13040335.